Infliximab therapy for moderately severe Crohn’s disease and ulcerative colitis: a retrospective comparison over 6 years

BACKGROUND: Infliximab has shown benefit in Crohn’s disease (CD) and ulcerative colitis (UC). OBJECTIVE: Evaluation of long-term outcome of therapy for both diseases. METHODS: We analyzed retrospectively patients treated at infusion centers from one institution. Demographic, laboratory parameters le...

Descripción completa

Detalles Bibliográficos
Autores principales: Alzafiri, Raed, Holcroft, Christina A, Malolepszy, Paula, Cohen, Albert, Szilagyi, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108681/
https://www.ncbi.nlm.nih.gov/pubmed/21694867
http://dx.doi.org/10.2147/CEG.S16168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108681/
https://www.ncbi.nlm.nih.gov/pubmed/21694867
http://dx.doi.org/10.2147/CEG.S16168

Ejemplares similares